TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kringle Pharma, Inc. ( (JP:4884) ) has issued an announcement.
Kringle Pharma, Inc. reported a decline in financial performance for the nine months ending June 30, 2025, with net sales decreasing by 12.4% compared to the previous year. The company experienced operating and ordinary losses, reflecting challenges in its financial operations, which may impact its market positioning and stakeholder interests.
More about Kringle Pharma, Inc.
Kringle Pharma, Inc. is a company listed on the Tokyo Stock Exchange, operating within the pharmaceutical industry. The company is focused on developing innovative treatments and has a market focus on advancing healthcare solutions.
Average Trading Volume: 142,526
Technical Sentiment Signal: Sell
Current Market Cap: Yen3.45B
For detailed information about 4884 stock, go to TipRanks’ Stock Analysis page.